Begin main content

Updates for Patient Groups - November 2014

November 1, 2014
Short Videos on Patient Input into the CADTH Common Drug Review CADTH recently produced four short videos describing: why CADTH values patient input what elements are most useful to reviewers and expert committee members in groups' patient input submissions how to submit input. Canadian Drug Expert Committee Public Member, Frank Gavin and former...

Updates for Patient Groups - October 2014

October 1, 2014
Technical difficulties resolved for patient input submissions We’ve had a few technical problems recently with our Common Drug Review patient input online submission system. Thank you for your patience and understanding while we investigated and fixed the problem. We’ve added  new safeguards to enable us to closer track submissions into our auto...

CADTH Announces New Members to Its Health Technology Expert Review Panel

September 10, 2014
Wednesday, September 10, 2014, Ottawa — Dr. Brian O’Rourke, President and CEO of CADTH, today announced the appointment of three new core members to the Health Technology Expert Review Panel: Jenny Basran, MD, FRCPC — Internist Geriatrician and Associate Professor in the Department of Medicine at the University of Saskatchewan Leslie Anne Campbe...

CADTH Announces New Chair and Vice-Chair of the Canadian Drug Expert Committee

September 3, 2014
September 3, 2014, Ottawa — Dr. Brian O’Rourke, President and CEO of CADTH, today announced changes to the leadership of the Canadian Drug Expert Committee. Dr. Lindsay Nicolle has been appointed the new Chair of the committee and Dr. James Silvius has been appointed Vice-Chair. Their appointments are for two and three-year terms respectively an...

Advisory Panel on Healthcare Innovation

June 24, 2014
June 24, 2014 - The creation of an Advisory Panel on Healthcare Innovation, announced earlier today by federal Health Minister Rona Ambrose, will help ensure all Canadians benefit from health innovation, said Dr. Brian O’Rourke, President and CEO of CADTH, the pan-Canadian health technology assessment agency. “There are two positive aspects to t...